If you’re a pharmaceutical company looking to introduce a new medicine to the Irish market, navigating the reimbursement process can be complex and time-consuming.
In this video you’ll gain a better understanding of the two routes to reimbursement in Ireland: Rapid Review and Health Technology Assessment (HTA).
The reimbursement process is officially triggered by submitting an application to the Corporate Pharmaceutical Unit (CPU). This application includes a Rapid Review submission, which determines whether a HTA is required or not based on the relative clinical benefit and relative cost of the new medicine. If a HTA is required, it is assessed by the National Centre for Pharmacoeconomics (NCPE). Timelines to reimbursement vary between the two routes. For example, it takes 357 and 914 days for medicines to be reimbursed following a Rapid Review and HTA respectively. The long timelines are due to price negotiations that are required post submissions to secure reimbursement.
Salutem Insights offers a comprehensive solution to help pharmaceutical companies navigate the Irish reimbursement process with ease. Their services include HTAs, Rapid Reviews, systematic literature reviews, expert elicitation, and burden of illness studies. By partnering with Salutem Insights, you can ensure that your reimbursement application is handled efficiently and effectively, allowing you to focus on bringing your medicine to patients in need.
Don’t let the reimbursement process be a roadblock to introducing your medicine in Ireland. Contact Salutem Insights today to learn more about how they can help you succeed.
In the rapidly evolving healthcare industry, market access is crucial for the successful launch of new products and services. Market access consultancy services play a pivotal role in helping organisations navigate the complexities of market entry, providing valuable local insights and strategies to maximise success. In this blog, we will explore the benefits of access consultancy services and how they can accelerate the launch of your healthcare product.
Market access consultancy services encompass a range of disciplines, including health economics and outcomes research (HEOR), economic modelling, and medical writing. By combining these fields, access consultancy firms can provide a comprehensive understanding of the market landscape and develop tailored strategies to achieve market access.
1 Healthcare providers: Ensuring that patients have access to the best treatments available
2 Payers and insurers: Making informed decisions on coverage and reimbursement
3 Pharmaceutical and medical device manufacturers: Successfully launching their products and maximising market potential
Market access consultancy services can help you identify key trends in market access. This information is vital for developing a successful market access strategy and finding the fastest route to reimbursement.
Market access consultancy services can also help you evaluate the clinical and cost-effectiveness of your product. By conducting a thorough Health Technology Assessment (HTA), access consultants can guide you in determining appropriate pricing and reimbursement strategies to ensure market access.
Economic modelling is another essential aspect of market access consultancy services. Consultants can help you develop budget impact models and cost-effectiveness analyses to support your market access strategy.
Market access consultants can also assist with the preparation of the clinical component of reimbursement submissions to ensure that the clinical value of your product is well understood.
When selecting a market access consultancy firm, consider the following criteria:
1 Expertise in health economics and outcomes research
2 Experience with economic modelling and medical writing
3 Proven success in market access
4 Insights into market access trends
Before partnering with a market access consultancy firm, ask the following questions:
1 What experience do they have with similar products and markets?
2 How well do they understand current market trends and challenges?
3 Are they committed to your organisation’s success? Will they reduce your workload?
In conclusion, market access consultancy services, like those offered by Salutem Insights, can provide invaluable support in the successful launch of your product. By leveraging their expertise in health economics, economic modelling, medical writing and latest market access insights, Salutem Insights can help you develop a comprehensive market access strategy that maximises your product’s potential. If you’re considering partnering with a market access consultancy firm, we encourage you to reach out to Salutem Insights for a consultation or further information to see how their team of experts can help your organisation succeed. Don’t miss this opportunity to unlock your product’s market potential – contact Salutem Insights today!